XBI $144.52 (-1.23%)
Covid:
$NVAX (-4%) - Agreement with NZ for 10.7M doses
Data Updates:
$AVDL (-8.5%) - Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA
$BCRX (-0.2%) - BioCryst Announces U.S. Availability of ORLADEYO™ (berotralstat) for the Treatment of Hereditary Angioedema
$BNTX (-5%) - BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine
$DRRX (+0.5%) - DURECT Corporation Announces DUR-928 Granted FDA Fast Track Designation for Treatment of Alcoholic Hepatitis
$ESPR (+2%) - First-in-class cholesterol-lowering treatment NILEMDO® * (bempedoic acid) tablet and its combination with ezetimibe NUSTENDI® * (bempedoic acid and ezetimibe) tablet approved in Switzerland
Financial Updates:
$PHAT - Prices offering at $42/share
$GMDA (-7%) - Announces public offering
Commentaires